Japan, Sept. 7 -- KYMAB LTD has got intellectual property rights for 'ANTIBODY, USE, AND METHOD.' Other related details are as follows:
Application Number: JP,2023-183313
Category (FI): A61P29/00,101,A61P1/04,A61K45/00,C12N15/13,C12P21/08,A61P43/00,121,C07K16/28,C12N15/63@Z,C12N5/10,A61P37/06,A61P29/00,A61K39/395@N,A61K39/395@D,A61P9/10,101,A61P25/00,A61P27/02,A61P3/10,A61P37/02,A61P19/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 25, 2023
Publication Date: Jan. 30, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....